Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
May 26, 2020
Primary Completion Date
June 26, 2020
Study Completion Date
June 26, 2020
Conditions
Disorders of Sphingolipid MetabolismHealthy Volunteers
Interventions
DRUG
venglustat
Powder for Oral solution
Trial Locations (1)
NG11 6JS
Investigational Site Number :8260001, Nottingham
All Listed Sponsors
lead
Genzyme, a Sanofi Company
INDUSTRY
NCT05238714 - Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male Subjects | Biotech Hunter | Biotech Hunter